FDA Inspection 1325472 — Antoine Hollebecque, M.D.

Antoine Hollebecque, M.D. — FEI 3043460371

The FDA completed an inspection of Antoine Hollebecque, M.D. on June 11, 2026 in Villejuif. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 11, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Villejuif (France)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance